Continuum Advisory’s Amphastar Pharmaceuticals AMPH Stock Holding History

Continuum Advisory’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$343	Buy	+17	New	+$343	﹤0.01%	1930

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Continuum Advisory's AMPH Position: Q2 2026 in Review

Continuum Advisory opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2026: 17 shares worth $343. The stake represents ﹤0.01% of the portfolio and ranks #1930 among its holdings.

210 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

Continuum Advisory held 17 shares of Amphastar Pharmaceuticals worth $343 as of Q2 2026.
Amphastar Pharmaceuticals was a new Continuum Advisory position in Q2 2026.
Amphastar Pharmaceuticals made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1930 holding.
210 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.